<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The recently described <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> syndrome (<z:chebi fb="21" ids="53713">APA</z:chebi>) is recognized because <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortion</z:e>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and repeated arterial and/or, <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> plus the demonstration of serum antibodies reactive with anionic <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 51 patients who attend the anticoagulation clinic at our Institute </plain></SENT>
<SENT sid="2" pm="."><plain>In a representative sample, we search for serum IgG specific for <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> using an standard assay </plain></SENT>
<SENT sid="3" pm="."><plain>We did not pick up unrecognized <z:chebi fb="21" ids="53713">APA</z:chebi> cases </plain></SENT>
<SENT sid="4" pm="."><plain>The low frequency of this condition could be an explanation for our negative results in non-selected cases </plain></SENT>
<SENT sid="5" pm="."><plain>Besides, this study denies a relationship between the <z:hpo ids='HP_0011010'>chronic</z:hpo> use of <z:chebi fb="2" ids="28794">coumarin</z:chebi> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> and development of peculiar antibodies </plain></SENT>
</text></document>